The White House just dropped $5 billion.
It’s called the Genesis Mission. And it isn’t subtle.
President Donald Trump announced these grants on Thursday. The money targets hundreds of AI-driven projects. The goal? Accelerate science through artificial intelligence. The administration compares this effort to the Manhattan Project. That is a heavy lift for a grant program. But they are aiming for it.
Simultaneously, Michael Kratsios, the president’s science adviser, was in Washington pushing a different narrative. He calls it a “New Golden Age” of American science.
This era prioritizes three things. Artificial intelligence. Robotics. Nuclear energy.
It explicitly steps back from life sciences.
This shift defines how the Trump administration wants to reshape the US research landscape. It marks the latest aggressive move in a broader campaign against the traditional research establishment.
Why the tech-bro approach fails basic science
Critics argue the strategy is fundamentally flawed.
“We may well end up in a situation where AI will have a few major Insights buried under mountains of slop.”
Andreas Karch, a physics professor at UT Austin, warns that the current output of AI-driven science is often low quality. He calls it “slop.”
The problem is expertise.
Universities train the humans who can distinguish between genuine breakthrough and algorithmic noise. If you cut university funding while boosting AI, you kill the very experts needed to verify the AI’s work. The result is a rapid decline in people capable of telling good science from bad.
The Genesis Mission covers 278 projects. These were chosen from over 5,000 applicants. They span drug discovery. Energy. Advanced materials. Robotics.
The Department of Energy leads this effort. They promise to unite national labs, industry, and academia. Tech giants are playing along. Google. Microsoft. OpenAI. They are providing compute power and credits.
This is not just a grant program. It is a structural change.
How the “Golden Age” manifesto shifts power
The underlying document, the “Golden Age” manifesto, frames this as a modern update to Vannevar Bush’s famous 1945 report Science, the Endless Frontier.
Bush’s report built the postwar US system. It emphasized open-ended basic research. The assumption was that free inquiry leads to applied breakthroughs.
The new manifesto flips this.
It moves support away from institutions. It shifts funding to individual scientists and private companies. It gives political appointees more power. They can now block grants they disagree with.
This sounds like a Silicon Valley playbook.
Venture capital loves speed. It demands measurable returns. It cuts projects that don’t hit targets. Science does not work that way.
Basic research takes decades. Its value is often invisible until much later. Many great discoveries were accidents. They happened while researchers asked different questions. You cannot force serendipity with a KPI dashboard.
Claes de Vreese, a professor at the University of Amsterdam, puts it bluntly.
“You cannot use venture capital to force breaks throughs while virtually already selling the patent.”
Which groups lose when science becomes a business
The Trump administration cites Bush’s name. But the policies dismantle the system he created.
There is some appeal to the administrative reforms. Scientists hate red tape. Everyone wants faster peer review. Jason Shepherd, a neurobiologist at the University of Utah, agrees on the need for stability and incentives for high-risk work.
But the document itself feels disconnected from reality.
Shepherd says it was written by political appointees who do not understand how academia works. Academic science is not a VC-backed startup.
Consider Kratsios’s background. He is not a scientist. He has no scientific credentials. His experience is in tech policy and finance. He worked for a fund run by Peter Thiel.
Researchers say this Silicon Valley mindset permeates the report. Jeffrey Flier, a former dean at Harvard Medical School, calls the approach “completely insane.” He sees it as a threat. It politicizes science. It tries to control outcomes before the work is even done.
There are contradictions everywhere.
The agenda proposes cutting support for “life sciences” while increasing support for “foundational biological research.” These terms overlap significantly. The report defines neither. No one knows which fields gain or lose money.
Andreas Karch argues the government believes future breakthroughs come from tech. He disagrees. Today’s scientific leadership creates tomorrow’s tech leadership. Big tech companies excel at engineering. They are not proven engines of basic discovery.
Who wins in the new science funding model
The broader context matters.
These grants arrive during sweeping cuts. Universities face budget shocks. Government agencies are in upheaval. Grant cancellations are common.
De Vreese sees this as an attack on US research universities. It is a departure from a successful model. It looks like an attempt to upend the system that made America a superpower.
Carl Bergstrom, a biologist at the University of Washington, warns of economic repercussions. Funding agencies do more than create tech. They build a STEM ecosystem.
This plan undercuts that role.
It views science through a narrow lens. It cares about applications. It ignores the slow, uncertain work that yields the biggest surprises.
This makes sense given the president’s stated philosophy. He runs the country like a business.
Most researchers doubt this plan brings a golden age. They fear lasting damage.
De Vreese offers a different perspective.
“This looks like a golden age for specifc groups and likely for tech and venture captains.”
For them, the sun is rising. For the rest of science, the clouds are gathering.
Academic science cannot be replaced by a balance sheet. The administration is trying anyway.
